Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats

Chinese Journal of Physiology

Volumn 50, Issue 6, 2007, Pages 283-293

  Hsu, Yung Hsiang ^a   Hsu, Bang Gee ^a   Chen, Hsing I ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Arteriolar injury; Glomerular injury; Nitric oxide synthase; Renal functions; Stroke

Indexed keywords

DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENZYME INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LYSINE; N(6) (1 IMINOETHYL)LYSINE; N(6)-(1-IMINOETHYL)LYSINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; S METHYLISOTHIOPSEUDOURONIUM; S-METHYLISOTHIOPSEUDOURONIUM; THIOUREA DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; KIDNEY; KIDNEY CIRCULATION; KIDNEY FUNCTION TEST; MUSCLE WEAKNESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UREA NITROGEN BLOOD LEVEL; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; BLOOD UREA NITROGEN; BODY WEIGHT; ENDOTHELIN-1; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HYPERTENSION; ISOTHIURONIUM; KIDNEY; KIDNEY FUNCTION TESTS; LYSINE; MUSCLE WEAKNESS; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; NITROARGININE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENAL CIRCULATION; VENTRICULAR FUNCTION, LEFT;

EID: 44349105260     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Arnal, J.F., el Amrani, A.I., Chatellier, G., Menard, J. and Michel, J.B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22: 380-387, 1993.
2. Arnal, J.F., Warin, L. and Michel, J.B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 90: 647-652, 1992.
3. Awolesi, M.A., Widmann, M.D., Sessa, W.C. and Sumpio, B.E. Cyclic strain increases endothelial nitric oxide synthase activity. Surgery 116: 439-444, 1994.
4. Baylis, C., Mitruka, B. and Deng, A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90: 278-281, 1992.
5. Benjamin, N. and Vane, J. Nitric oxide and hypertension. Circulation 94: 1197-1198, 1996.
6. Blot, S., Arnal, J.F., Xu, Y., Gray, F. and Michel, J.B. Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke 25: 1666-1673, 1994.
7. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72: 248-254, 1976.
8. Buxton, I.L., Cheek, D.J., Eckman, D., Westfall, D.P., Sanders, K.M. and Keef, K.D. NG-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72: 387-395, 1993.
9. Chang, H.R., Lee, R.P., Wu, C.Y. and Chen, H.I. Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin. Exp. Pharmacol. Physiol. 29: 275-280, 2002.
10. Chen, H.I. and Hu, C.T. Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats. Am. J. Physiol. 273: H1816-H1823, 1997.
11. Chen, H.I., Hu, C.T., Wu, C.Y. and Wang, D. Nitric oxide in systemic and pulmonary hypertension. J. Biomed. Sci. 4: 244-248, 1997.
12. de Belder, A.J. and Radomski, M.W. Nitric oxide in the clinical arena. J. Hypertens. 12: 617-624, 1994.
13. Fischer, P.A., Dominguez, G.N., Cuniberti, L.A., Martinez, V., Werba, J.P., Ramirez, A.J. and Masnatta, L.D. Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved? J. Am. Soc. Nephrol. 14: 653-660, 2003.
14. Fitch, R.M., Vergona, R., Sullivan, M.E. and Wang, Y.X. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc. Res. 51: 351-358, 2001.
15. Frohlich, E.D. Approaches to the Treatment of Patients with Stroke and Hypertensive Emergencies. In: Frohlich eds. Hypertension Evaluation and Treatment. Baltimore: Williams and Wilkins 1998: 165-195.
16. Harrison, D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100: 2153-2157, 1997.
17. Hayakawa, H. and Raij, L. Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31: 266-270, 1998.
18. Hayakawa, H. and Raij, L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension 29: 235-241, 1997.
19. Hill, C., Lateef, A.M., Engels, K., Samsell, L. and Baylis, C. Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am. J. Physiol. 272: R1747-R1753, 1997.
20. Hsieh, N.K., Wang, J.Y., Liu, J.C., Lee, W.H. and Chen, H.I. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats. Thromb. Haemost. 92: 162-170, 2004.
21. Hsieh, N.K., Wang, J.Y., Liu, J.C., Wang, S.D. and Chen, H.I. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats. Clin. Exp. Pharmacol. Physiol. 31: 212-218, 2004.
22. Hu, C.T., Chang, K.C., Kuo, T.S. and Chen, H.I. The correlation of cardiac mass with arterial haemodynamics of resistive and capacitive load in rats with normotension and established hypertension. Pflugers. Arch. 428: 533-541, 1994.
23. Hu, C.T., Chang, K.C., Wu, C.Y. and Chen, H.I. Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat. Br. J. Pharmacol. 122: 1237-1243, 1997.
24. Huang, P.L., Huang, Z., Mashimo, H., Bloch, K.D., Moskowitz, M.A., Bevan, J.A. and Fishman, M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
25. Ishii, N., Patel, K.P., Lane, P.H., Taylor, T., Bian, K., Murad, F., Pollock, J.S. and Carmines, P.K. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J. Am. Soc. Nephrol. 12: 1630-1639, 2001.
26. Kalliovalkama, J., Jolma, P., Tolvanen, J.P., Kahonen, M., Hutri-Kahonen, N., Wu, X., Holm, P. and Porsti, I. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism. Cardiovasc. Res. 42: 773-782, 1999.
27. Kolpakov, V., Gordon, D. and Kulik, T.J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76: 305-309, 1995.
28. Komatsu, K., Frohlich, E.D., Ono, H., Ono, Y., Numabe, A. and Willis, G.W. Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of angiotensin-converting enzyme inhibition. Hypertension 25: 207-213, 1995.
29. Lee, R.P., Wang, D., Lin, N.T. and Chen, H.I. Physiological and chemical indicators for early and late stages of sepsis in conscious rats. J. Biomed. Sci. 9: 613-621, 2002.
30. Li, J. and Bukoski, R.D. Endothelium-dependent relaxation of hypertensive resistance arteries is not impaired under all conditions. Circ. Res. 72: 290-296, 1993.
31. Mai, M., Geiger, H., Hilgers, K.F., Veelken, R., Mann, J.F., Dammrich, J. and Luft, F.C. Early interstitial changes in hypertension-induced renal injury. Hypertension 22: 754-765, 1993.
32. Moncada, S., Palmer, R.M. and Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
33. Ono, H., Ono, Y. and Frohlich, E.D. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics. Hypertension 26: 249-255, 1995.
34. Panza, J.A., Garcia, C.E., Kilcoyne, C.M., Quyyumi, A.A. and Cannon, R.O. 3rd. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 91: 1732-1738, 1995.
35. Pritchard, K.A. Jr, Ackerman, A.W., Gross, E.R., Stepp, D.W., Shi, Y., Fontana, J.T., Baker, J.E. and Sessa, W.C. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J. Biol. Chem. 276: 17621-17624, 2001.
36. Raij, L. Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy. Hypertension 31: 189-193, 1998.
37. Sabbatini, M., Pisani, A., Uccello, F., Serio, V., Seru, R., Paterno, R., Cianciaruso, B., Fuiano, G. and Andreucci, M. Atorvastatin improves the course of ischemic acute renal failure in aging rats. J. Am. Soc. Nephrol. 15: 901-909, 2004.
38. Scholze, A., Rinder, C., Beige, J., Riezler, R., Zidek, W. and Tepel, M. Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation 109: 369-374, 2004.
39. Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Sudano, I. and Salvetti, A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94: 1298-1303, 1996.
40. Takemoto, M., Egashira, K., Usui, M., Numaguchi, K., Tomita, H., Tsutsui, H., Shimokawa, H., Sueishi, K. and Takeshita, A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99: 278-287, 1997.
41. Tsuruda, T., Costello-Boerrigter, L.C. and Burnett, J.C. Jr. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail. Rev. 9: 53-61, 2004.
42. Zatz, R. and Baylis, C. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.